Differentiating COPD exacerbations from pneumonia in COPD patients

Symposium
Chairs: Arturo Humberto Huerta Garcia (Barcelona, Spain), Wisia Wedzicha (London, United Kingdom)
Aims: To describe the clinical, biological (biomarkers), and physiological approaches that can be used to differentiate between OPD exacerbations from pneumonia in COPD patients.
Target audience: Clinicians.

How can I differentiate community-acquired pneumonia (CAP)+COPD patients from acute exacerbation of COPD (AECOPD) patients? Antoni Torres Marti (Barcelona, Spain)
How can I differentiate AECOPD from CAP+COPD patients? John R Hurst (London, United Kingdom)
Should we change our antibiotic strategy in AECOPD or CAP+COPD patients? Stefano Aliberti (Milan, Italy)